Sangimino et al v. Bayer Corporation et al
Filing
23
ORDER RE JOINT STIPULATION RE: BRIEFING SCHEDULES ON DEFENDANTS' MOTION TO DISMISS AND PLAINTIFFS' MOTION TO REMAND, Motions terminated: 22 STIPULATION WITH PROPOSED ORDER re 12 MOTION to Dismiss Plaintiffs' Complaint and Notice of Motion; Memorandum of Points and Authorities in Support, 18 MOTION to Remand BRIEFING SCHEDULES filed by Bayer Essure Inc., Bayer HealthCare Pharmaceuticals Inc., Bayer Corporation, Bayer HealthCare LLC ., Set/Reset Deadlines as to 12 MOTION to Dismiss Plaintiffs' Complaint and Notice of Motion; Memorandum of Points and Authorities in Support, 22 STIPULATION WITH PROPOSED ORDER re 12 MOTION to Dismiss Plaintiffs' C omplaint and Notice of Motion; Memorandum of Points and Authorities in Support, 18 MOTION to Remand BRIEFING SCHEDULES, 18 MOTION to Remand . Responses due by 4/28/2017. Replies due by 5/12/2017. Motion Hearing set for 6/8/2017 08:00 AM in Courtroom 8, 19th Floor, San Francisco before Hon. William Alsup.. Signed by Judge Alsup on 4/12/17. (whalc1, COURT STAFF) (Filed on 4/12/2017)
1
2
3
4
5
6
7
8
Alycia A. Degen, SBN 211350
adegen@sidley.com
Bradley J. Dugan, SBN 271870
bdugan@sidley.com
SIDLEY AUSTIN LLP
555 West Fifth Street, Suite 4000
Los Angeles, California 90013
Telephone: +1 213 896-6000
Facsimile: +1 213 896-6600
Attorneys for Defendants and Specially
Appearing Defendants Bayer Corporation,
Bayer Essure Inc., Bayer HealthCare LLC,
Bayer HealthCare Pharmaceuticals Inc.
9
UNITED STATES DISTRICT COURT
10
NORTHERN DISTRICT OF CALIFORNIA
11
12
13
14
15
16
17
18
19
20
21
22
)
)
)
Plaintiffs,
)
)
vs.
)
)
BAYER CORP.; BAYER HEALTHCARE
)
LLC; BAYER ESSURE INC., (F/K/A
CONCEPTUS, INC.); BAYER HEALTHCARE )
PHARMACEUTICALS, INC.; and DOES 1-10, )
)
inclusive,
)
)
Defendants.
)
)
)
)
)
)
ELIZABETH ANN SANGIMINO, et al.,
Case No. 3:17-cv-01488-WHA
Order re:
JOINT STIPULATION RE:
BRIEFING SCHEDULES ON
DEFENDANTS’ MOTION TO
DISMISS AND PLAINTIFFS’
MOTION TO REMAND
23
24
25
26
27
28
Order re:
JOINT STIPULATION RE: BRIEFING SCHEDULES; CASE NO. 3:17-cv-01488-WHA
1
Plaintiffs Elizabeth Ann Sangimino, et al., and defendants and specially-appearing
2
defendants Bayer Corporation, Bayer Essure Inc., Bayer HealthCare LLC, and Bayer HealthCare
3
Pharmaceuticals Inc. (collectively, “Bayer”), hereby stipulate and agree as follows:
4
5
6
1.
Plaintiffs filed their complaint on February 16, 2017, in the Superior Court for the
State of California, County of Contra Costa.
2.
On March 20, 2017, Bayer removed the matter from the Contra Costa County
7
Superior Court to the United States District Court for the Northern District of California. [Dkt. No.
8
1]. The matter was assigned to the Honorable Phyllis J. Hamilton.
9
3.
Bayer filed its Motion to Dismiss on March 27, 2017, on the grounds of federal
10
preemption, among other grounds. [Dkt. No. 12]. The Motion to Dismiss was originally scheduled
11
for hearing on May 10, 2017.
12
4.
On March 30, 2017, this action was transferred to this Court pursuant to the Court’s
13
Order Relating Cases. [Dkt. No. 16]. In its Order Relating Cases, the Court instructed Bayer to re-
14
notice its Motion to Dismiss for hearing. [Id.].
15
5.
On March 31, 2017, Plaintiffs filed their Motion to Remand and Motion to Stay
16
Proceedings Pending Ruling on Motion to Remand. [Dkt. Nos. 18 & 19]. On that same day, the
17
Court scheduled the Initial Case Management Conference for May 11, 2017. [Dkt. No. 20].
18
6.
The Court denied the Motion to Stay on April 3, 2017, on the grounds that “[t]he
19
issues in defendants’ motion to dismiss are closely related to their alleged basis for removal, and the
20
Court will benefit from reviewing the briefing on both motions before ruling on either one, if not
21
hearing argument on both simultaneously.” [Dkt. No. 21 at 1:19-22].
22
7.
In light of the Court’s April 3 order, the parties have met and conferred and, to
23
accommodate the Court’s April 3 Order and the schedules of the parties, agree and ask the Court to
24
enter the following briefing and hearing schedule on Bayer’s Motion to Dismiss and Plaintiffs’
25
Motion to Remand:
26
27
•
April 28, 2017: Bayer’s deadline to respond to Plaintiffs’ Motion to Remand;
Plaintiffs’ deadline to respond to Bayer’s Motion to Dismiss;
28
Order re:
1
JOINT STIPULATION RE: BRIEFING SCHEDULES; CASE NO. 3:17-cv-01488-WHA
•
1
Plaintiffs’ deadline to file a reply in support of the Motion to Remand;
2
•
3
4
May 12, 2017: Bayer’s deadline to file a reply in support of the Motion to Dismiss;
8.
June 8, 2017: Hearing on Motion to Dismiss and Motion to Remand.
The parties additionally agree that it would be in the interest of judicial economy to
5
continue the Initial Case Management Conference scheduled for May 11, 2017 to June 8, 2017, or to
6
a date thereafter that would permit the parties to accommodate the Court’s rulings on the Motion to
7
Remand and Motion to Dismiss.
8
IT IS SO STIPULATED.
9
Dated: April 7, 2017
SIDLEY AUSTIN LLP
10
By: /s/ Alycia A. Degen
Alycia A. Degen
Bradley J. Dugan
11
12
Attorneys for Defendants and Specially
Appearing Defendants
Bayer Corporation, Bayer HealthCare LLC,
Bayer Essure Inc., and Bayer HealthCare
Pharmaceuticals Inc.
13
14
15
16
Dated: April 7, 2017
MOTLEY RICE, LLC
By: /s/ Breanne V. Cope
Breanne V. Cope
17
18
Attorneys for Plaintiffs
Elizabeth Ann Sangimino, et al.
19
20
Filer’s Attestation: Pursuant to Local Rule 5-1(i)(3), regarding signatures, Alycia A. Degen hereby
21
attests that concurrence in the filing of this document has been obtained from counsel for Plaintiffs.
22
Dated: April 6, 2017
23
By: /s/ Alycia A. Degen
Alycia A. Degen
24
25
26
27
28
Order re:
2
JOINT STIPULATION RE: BRIEFING SCHEDULES; CASE NO. 3:17-cv-01488-WHA
1
[PROPOSED] ORDER
2
PURSUANT TO THE PARTIES’ STIPULATION, and for good cause shown, IT IS
3
ORDERED THAT:
a.
4
response to the Motion to Remand, on or before April 28, 2017.
5
b.
6
c.
8
The hearings on the Motion to Dismiss and Motion to Remand are scheduled for June
8, 2017, at 8:00 a.m.
d.
10
11
Plaintiffs shall file their reply in support of the Motion to Remand, and Bayer shall
file its reply in support of its Motion to Dismiss, on or before May 12, 2017.
7
9
Plaintiffs shall file their response to the Motion to Dismiss, and Bayer shall file its
The Initial Case Management Conference is continued to June 8, 2017 at 8:00 a.m.,
and the parties shall file their joint case management statement on or before June 1, 2017.
12
13
Dated: April 12 2017
__,
___________________________________
Honorable William H. Alsup
14
15
16
17
18
19
20
21
22
23
Order re:
24
25
26
27
28
220865600
1
[PROPOSED] ORDER - CASE NO. 3:17-cv-01488-WHA
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?